Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-036965
Filing Date
2024-08-13
Accepted
2024-08-13 16:59:47
Documents
73
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gral-20240630.htm   iXBRL 10-Q 1912092
2 EX-31.1 CEO CERTIFICATION ex-311ceosection302certifi.htm EX-31.1 9173
3 EX-31.2 CFO CERTIFICATION ex-312cfosection302certifi.htm EX-31.2 9150
4 EX-32.1 CEO SECTION 906 CERTIFICATION ex-321ceosection906certifi.htm EX-32.1 4674
5 EX-32.2 CFO SECTION 906 CERTIFICATION ex-322cfosection906certifi.htm EX-32.2 4651
  Complete submission text file 0001628280-24-036965.txt   7576116

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gral-20240630.xsd EX-101.SCH 43980
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gral-20240630_cal.xml EX-101.CAL 70016
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gral-20240630_def.xml EX-101.DEF 313623
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gral-20240630_lab.xml EX-101.LAB 565833
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gral-20240630_pre.xml EX-101.PRE 458560
76 EXTRACTED XBRL INSTANCE DOCUMENT gral-20240630_htm.xml XML 935330
Mailing Address 1525 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1525 O'BRIEN DRIVE MENLO PARK CA 94025 650-771-9796
GRAIL, Inc. (Filer) CIK: 0001699031 (see all company filings)

EIN.: 863673636 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42045 | Film No.: 241202651
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)